Skip Nav Destination
A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer
Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation
Issue Archive
Table of Contents
PLENARY PAPERS
A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
Clinical Trials & Observations
Oliver W. Press,Janet F. Eary,Ted Gooley,Ajay K. Gopal,Stephen Liu,Joseph G. Rajendran,David G. Maloney,Stephen Petersdorf,Sharon A. Bush,Lawrence D. Durack,Paul J. Martin,Darrell R. Fisher,Brent Wood,James W. Borrow,Bruce Porter,Justin P. Smith,Dana C. Matthews,Frederick R. Appelbaum,Irwin D. Bernstein
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
Teru Hideshima,Dharminder Chauhan,Yoshihito Shima,Noopur Raje,Faith E. Davies,Yu-Tzu Tai,Steven P. Treon,Boris Lin,Robert L. Schlossman,Paul Richardson,George Muller,David I. Stirling,Kenneth C. Anderson
REVIEW ARTICLES
CHEMOKINES
T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease
Jonathan S. Serody,Susan E. Burkett,Angela Panoskaltsis-Mortari,Judith Ng-Cashin,Eileen McMahon,Glenn K. Matsushima,Sergio A. Lira,Donald N. Cook,Bruce R. Blazar
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
Clinical Trials & Observations
Ian W. Flinn,Kenneth J. Kopecky,M. Kathryn Foucar,David Head,John M. Bennett,Robert Hutchison,William Corbett,Peter Cassileth,Thomas Habermann,Harvey Golomb,Kanti Rai,Elizabeth Eisenhauer,Frederick Appelbaum,Bruce Cheson,Michael R. Grever
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma
Clinical Trials & Observations
Marie-Hélène Delfau-Larue,Liliane Laroche,Janine Wechsler,Eric Lepage,Chantal Lahet,Marianne Asso-Bonnet,Martine Bagot,Jean-Pierre Farcet
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
Clinical Trials & Observations
Ritsuro Suzuki,Yoshitoyo Kagami,Kengo Takeuchi,Masahiro Kami,Masataka Okamoto,Ryo Ichinohasama,Naoyoshi Mori,Masaru Kojima,Tadashi Yoshino,Hirohiko Yamabe,Mami Shiota,Shigeo Mori,Michinori Ogura,Nobuyuki Hamajima,Masao Seto,Taizan Suchi,Yasuo Morishima,Shigeo Nakamura
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer
Clinical Trials & Observations
Ian McNiece,Roy Jones,Scott I. Bearman,Pablo Cagnoni,Yago Nieto,Wilbur Franklin,John Ryder,Andrea Steele,Judy Stoltz,Peggy Russell,Janet McDermitt,Christopher Hogan,James Murphy,Elizabeth J. Shpall
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
Clinical Trials & Observations
Janos Sumegi,Dali Huang,Arpad Lanyi,Jack D. Davis,Thomas A. Seemayer,Akihiko Maeda,George Klein,Marco Seri,Hiroshi Wakiguchi,David T. Purtilo,Thomas G. Gross
UTY gene codes for an HLA-B60–restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition
Mario H. J. Vogt,Els Goulmy,Freke M. Kloosterboer,Els Blokland,Roel A. de Paus,Roel Willemze,J. H. Frederik Falkenburg
NEOPLASIA
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
Steven P. Treon,Peter Maimonis,Deborah Bua,Gloria Young,Noopur Raje,Joseph Mollick,Dharminder Chauhan,Yu-Tzu Tai,Teru Hideshima,Yoshihito Shima,Jo Hilgers,Silvia von Mensdorff-Pouilly,Andrew R. Belch,Linda M. Pilarski,Kenneth C. Anderson
PHAGOCYTES
RED CELLS
BRIEF REPORTS
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Clinical Trials & Observations
Brief Report
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation
Clinical Trials & Observations
Brief Report
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement
Email alerts
Advertisement